PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
NCT ID: NCT01617954
Last Updated: 2016-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
820 participants
OBSERVATIONAL
2012-05-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry
NCT02670577
PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)
NCT02269813
MammaPrint Value for Pre-menopausal Breast Cancer Patients
NCT05474391
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
NCT00003854
Partial Breast Proton Therapy for Early Stage Breast Cancer
NCT01310530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with MammaPrint Result
MammaPrint
All subjects
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MammaPrint
All subjects
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥ 18 years of age at time of consent
* Written informed consent
Exclusion Criteria
* Tumor sample shipped to Agendia with ≤ 30% tumor cells or that fails QA or QC criteria
* Women who have started or completed adjuvant chemotherapy or neo-adjuvant chemotherapy
18 Years
90 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agendia
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michaela Tsai, MD
Role: PRINCIPAL_INVESTIGATOR
Piper Breast Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maricopa Integrated Health System
Phoenix, Arizona, United States
Providence Saint Joseph Medical Center
Burbank, California, United States
Comprehensive Cancer Center
Palm Springs, California, United States
Breastlink
Santa Ana, California, United States
Redwood Regional Cancer Center
Santa Rosa, California, United States
Exempla Saint Joseph Hospital
Denver, Colorado, United States
Stamford Hospital
Stamford, Connecticut, United States
The Breast Institute at JFK Medical
Atlantis, Florida, United States
Halifax Health Center for Oncology
Daytona Beach, Florida, United States
Broward Health Medical Center
Fort Lauderdale, Florida, United States
Regional Breast/21st Century Oncology
Fort Myers, Florida, United States
Northeast Georgia Cancer Care
Athens, Georgia, United States
Dekalb Medical Center
Decatur, Georgia, United States
Northeast Georgia Medical Center
Gainesville, Georgia, United States
Loyola University Medical Center
Chicago, Illinois, United States
Alexian Brothers Medical Center
Elk Grove Village, Illinois, United States
Delnor Community Hospital
Geneva, Illinois, United States
Ingalls Memorial Hospital
Harvey, Illinois, United States
Orchard Healthcare Research
Northbrook, Illinois, United States
CDH Cancer Center
Winfield, Illinois, United States
IU Health Bloomington
Bloomington, Indiana, United States
Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
Covenant Medical Center
Waterloo, Iowa, United States
MedStar Harbor Hospital
Baltimore, Maryland, United States
Harry & Jeanette Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland, United States
Mercy Medical Center
Baltimore, Maryland, United States
Western Maryland Health System
Cumberland, Maryland, United States
Lahey Clinic
Burlington, Massachusetts, United States
Mount Auburn Hospital
Cambridge, Massachusetts, United States
MetroWest Medical Center
Framingham, Massachusetts, United States
St. Vincent Hospital
Worcester, Massachusetts, United States
Detroit Clinical Research Center
Detroit, Michigan, United States
Virginia Piper Cancer Institute
Minneapolis, Minnesota, United States
St. Louis Cancer Care
Bridgeton, Missouri, United States
SSM Cancer Center
St Louis, Missouri, United States
Roswell Park Cancer Center
Buffalo, New York, United States
North Shore/Monter Cancer Center
Lake Success, New York, United States
Columbia University
New York, New York, United States
University of Oklahoma
Oklahoma City, Oklahoma, United States
Tulsa Cancer Institute
Tulsa, Oklahoma, United States
St. Mary Medical Center
Langhorne, Pennsylvania, United States
St. Clair Hospital
Pittsburgh, Pennsylvania, United States
Charleston Cancer Center
Charleston, South Carolina, United States
Cookeville Regional Medical Center
Cookeville, Tennessee, United States
Knoxville Comprehensive Breast Center
Knoxville, Tennessee, United States
Nashville Breast Center
Nashville, Tennessee, United States
Texas Health
Dallas, Texas, United States
Hematology/Oncology Associates
Alexandria, Virginia, United States
Lynchburg Hematology Oncology Clinic
Lynchburg, Virginia, United States
Swedish Cancer Institute
Seattle, Washington, United States
Columbia St. Mary's Cancer Center
Milwaukee, Wisconsin, United States
Aurora Advanced Healthcare
Milwaukee, Wisconsin, United States
Wheaton Franciscan Cancer Care - All Saints
Racine, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROMIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.